the significance of canine parvovirus ( cpv ) infections as a permanent threat susceptible dogs , in particular pups , made the authors develop three liquid homologous inactivated adjuvant cpv vaccines that were compatible with existing canine vaccines and could be incorporated in current vaccination programmes .
C0042212
inactivated
C0042210
vaccines